Contact Sekisui Customer Service for use on Abbott ARCHITECT and Ortho Vitros® 4600 and 5600 automated clinical chemistry systems.
Levetiracetam (KEPPRA®) is an anti-convulsant drug approved for use as adjunctive therapy in the treatment of epilepsy. The ARK™ Levetiracetam Assay is intended for the quantitative determination of levetiracetam in human serum or plasma on automated clinical chemistry analyzers. Levetiracetam concentrations can be used as an aid in management of patients treated with levetiracetam
- Convenient, liquid-stable, ready to use
- Tested drugs and endogenous substances do not interfere
- Nonhazardous preservatives contain no sodium azide
- Excellent calibration range
ARK™ is a trademark of ARK Diagnostics, Inc.
Keppra® is a Registered Trademark of UCB
Product Availability: USA
Sample Type: Serum and Plasma
Safety Data Sheets
Contact us to get more information, become part of our distribution network, or ask a question about our products and their availability in your region:
||R1 1 x 28mL, R2 1 x 14mL|
||1 x 4mL, 5 x 2mL|
||3 x 4mL|